Back
Ligand Pharmaceuticals Vs. DXP Enterprises Industry Stock Comparison
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
$113.38
Seasonality Move:
9.17%
Buy
78
DXPE
DXP Enterprises
Last Price:
$81.37
Seasonality Move:
41.79%
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
-
The current Ligand Pharmaceuticals [LGND] share price is $113.80. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
-
The current DXP Enterprises [DXPE] share price is $79.89. The Score for DXPE is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
DXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $113.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $79.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 45.5 | Sell |
Chaikin Money Flow: | -76253 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.14 - 122.4) | Sell |
Bollinger Bands (100): | (100.52 - 116.88) | Buy |
DXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.56 | Buy |
Relative Strength Index (14 RSI): | 70.32 | Buy |
Chaikin Money Flow: | 168820 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.25 - 79.49) | Buy |
Bollinger Bands (100): | (47.51 - 69.91) | Buy |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.23 | Sell |
20-day SMA: | 119.3 | Sell |
50-day SMA: | 115.23 | Sell |
200-day SMA: | 95.57 | Buy |
8-day EMA: | 116.1 | Sell |
20-day EMA: | 117.33 | Sell |
50-day EMA: | 114.73 | Sell |
200-day EMA: | 99.09 | Buy |
DXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.36 | Buy |
20-day SMA: | 76.94 | Buy |
50-day SMA: | 66.27 | Buy |
200-day SMA: | 54.44 | Buy |
8-day EMA: | 78.92 | Buy |
20-day EMA: | 76.33 | Buy |
50-day EMA: | 69.05 | Buy |
200-day EMA: | 54.99 | Buy |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.48 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.24 per share.
Ligand Pharmaceuticals Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DXP Enterprises Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |